Gene Therapy for Parkinson?s Disease: Targeting Dopamine Replacement and Cell Function Modulation
Received Date: Jul 01, 2024 / Published Date: Jul 30, 2024
Abstract
Parkinson’s disease (PD) is a progressive neurological disorder characterized by motor and cognitive impairments due to the loss of dopamine-producing neurons. Traditional treatments focus on dopamine replacement through pharmacological means, yet these therapies have limitations and do not halt disease progression. Gene therapy presents a promising alternative by potentially modifying cellular behavior to replace lost dopamine or mitigate disease progression. This approach involves altering the function of specific genes to either restore dopamine production or correct harmful cellular activities. Current research is exploring various gene therapy techniques to improve outcomes for individuals with Parkinson’s disease, offering hope for more effective and targeted treatments.
Citation: Benjamin P (2024) Gene Therapy for Parkinson’s Disease: Targeting Dopamine Replacement and Cell Function Modulation J Dement 8: 231. Doi: 10.4172/dementia.1000231
Copyright: © 2024 Benjamin P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
51黑料吃瓜网 Journals
Article Tools
Article Usage
- Total views: 787
- [From(publication date): 0-2024 - Jun 23, 2025]
- Breakdown by view type
- HTML page views: 575
- PDF downloads: 212
